{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-23-000086","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.559411+00:00","generated_at":"2026-06-12T17:18:13.908974+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Penumbra Q2 revenue $261.5M +25.5% YoY; raises FY2023 guidance to $1.05-1.07B","bullets":["Revenue $261.5M (+25.5% YoY constant currency), U.S. 71%, international 29%.","Vascular segment $152.7M (+23.6%), neuro segment $108.8M (+28.3%).","GAAP operating income $17.9M vs loss $0.1M; non-GAAP operating income $20.3M vs $1.6M.","Gross margin 63.8% vs 64.3% YoY; R&D $21.5M, SG&A $127.4M.","FY2023 revenue guidance raised to $1.05-1.07B (24-26% growth); vascular to outpace, neuro below."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-23-000086","json":"https://secwatch.observer/filing/0001321732-23-000086.json","markdown":"https://secwatch.observer/filing/0001321732-23-000086.md","text":"https://secwatch.observer/filing/0001321732-23-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000086/0001321732-23-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000086/pen-20230801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T17:18:13.908974+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22aa834703e9eec3afb6fb1593f2f71a715be937","claim":"Penumbra Inc reported second quarter ended June 30, 2023 results: revenue $261.5 million.","evidence_excerpt":"Revenue of $261.5 million in the second quarter of 2023, an increase of 25.5% as reported and in constant currency 1 compared to the second quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000086/0001321732-23-000086-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$261.5 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ab084638ee7e26c8950963356c014652ca73d1f6","claim":"Penumbra Inc reported full year 2023 results: revenue $1.05 billion to $1.07 billion. Guidance raised.","evidence_excerpt":"The Company is increasing its guidance for 2023 total revenue to be in the range of $1.05 billion to $1.07 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000086/0001321732-23-000086-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"$1.05 billion to $1.07 billion"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}